- Home
- DTST vs HCWB Comparison
DTST vs HCWB Comparison
Compare DTST & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- HCWB
- Stock Information
- Founded
- DTST 2001
- HCWB 2018
- Country
- DTST United States
- HCWB United States
- Employees
- DTST N/A
- HCWB N/A
- Industry
- DTST EDP Services
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- HCWB Health Care
- Exchange
- DTST Nasdaq
- HCWB Nasdaq
- Market Cap
- DTST 28.3M
- HCWB 26.6M
- IPO Year
- DTST N/A
- HCWB 2021
- Fundamental
- Price
- DTST $4.88
- HCWB $0.44
- Analyst Decision
- DTST
- HCWB
- Analyst Count
- DTST 0
- HCWB 0
- Target Price
- DTST N/A
- HCWB N/A
- AVG Volume (30 Days)
- DTST 71.8K
- HCWB 365.0K
- Earning Date
- DTST 11-14-2024
- HCWB 11-14-2024
- Dividend Yield
- DTST N/A
- HCWB N/A
- EPS Growth
- DTST N/A
- HCWB N/A
- EPS
- DTST 0.02
- HCWB N/A
- Revenue
- DTST $25,143,911.00
- HCWB $3,495,990.00
- Revenue This Year
- DTST $2.57
- HCWB $229.19
- Revenue Next Year
- DTST $11.16
- HCWB N/A
- P/E Ratio
- DTST $242.41
- HCWB N/A
- Revenue Growth
- DTST 1.64
- HCWB 22.27
- 52 Week Low
- DTST $2.76
- HCWB $0.28
- 52 Week High
- DTST $8.00
- HCWB $2.52
- Technical
- Relative Strength Index (RSI)
- DTST 61.46
- HCWB 49.35
- Support Level
- DTST $3.98
- HCWB $0.40
- Resistance Level
- DTST $4.34
- HCWB $0.48
- Average True Range (ATR)
- DTST 0.32
- HCWB 0.06
- MACD
- DTST 0.02
- HCWB 0.01
- Stochastic Oscillator
- DTST 91.84
- HCWB 72.56
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.